Navigation Links
Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam
Date:1/19/2012

ylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.

This press release includes statement that may constitute "forward-looking statements" (including with regard to product launches and the company's strategies) as well as other information that is necessarily subject to risks, uncertainties and assumptions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Because such statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, market acceptance of the company's products, the impact of competition and the other risks detailed in the company's filings with the Securities and Exchange Commission. The company undertakes no obligation to update these statements for revisions or changes after the date of this release.

(1)  Levetiracetam in Sodium Chloride Injection for Intravenous Use is an antiepileptic drug indicated for adults (16 years and older) with the following seizure types when oral administration is temporarily not feasible: Partial onset seizures; Myoclonic seizures in patients with juvenile myoclonic epilepsy; Primary general
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. Mylan Receives Approval for Generic Version of GoLytely(R)
7. Mylan Declares Quarterly Preferred Stock Dividend
8. Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
9. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... FRANCISCO , July 28, 2014  Dignity ... it has received the Get With The Guidelines®-Stroke ... improvement measures outlined by the American Heart Association/American ... Stroke is the number four cause of death ... the United States , according ...
(Date:7/28/2014)... Calif. , July 28, 2014 STAAR ... developer, manufacturer and marketer of implantable lenses and delivery ... its second quarter results and conference call with investors ... July 30, 2014.  The Company rescheduled the release date ... the funeral services for Hideo Watanabe , President ...
(Date:7/28/2014)... July 28, 2014  MiMedx Group, Inc. (NASDAQ: MDXG ... regenerative biomaterials and bioimplants processed from human amniotic membrane, announced ... Highlights include: , Revenue exceeds ... 2013 to $25.6 million , Quarter-over-quarter ... Care revenue increases 181% over Q2 2013 and 40% sequentially ...
Breaking Medicine Technology:Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31 2MiMedx Announces Record Second Quarter Results 2MiMedx Announces Record Second Quarter Results 3MiMedx Announces Record Second Quarter Results 4MiMedx Announces Record Second Quarter Results 5MiMedx Announces Record Second Quarter Results 6MiMedx Announces Record Second Quarter Results 7MiMedx Announces Record Second Quarter Results 8MiMedx Announces Record Second Quarter Results 9MiMedx Announces Record Second Quarter Results 10MiMedx Announces Record Second Quarter Results 11MiMedx Announces Record Second Quarter Results 12MiMedx Announces Record Second Quarter Results 13MiMedx Announces Record Second Quarter Results 14MiMedx Announces Record Second Quarter Results 15MiMedx Announces Record Second Quarter Results 16MiMedx Announces Record Second Quarter Results 17MiMedx Announces Record Second Quarter Results 18
(Date:7/29/2014)... Premier Women’s Health , a six-physician ... has affiliated with Allegheny Health Network’s renowned Women’s Health ... babies and perform surgical procedures at Heritage Valley Sewickley. ... referred to Allegheny Health Network’s West Penn Hospital ... West Penn Hospital and its highly regarded Women’s Health ...
(Date:7/29/2014)... IsoComforter, Inc ., one of ... today the introduction of the innovative new Iso-Hip Wrap. ... created for post operative hip replacement patients. The plush ... the benefits of cold therapy while resting, sitting, or ... replacements are done every year. Cold therapy is ...
(Date:7/29/2014)... According to the new market research report, ... Material (Optical Prism, Pizeoelectric, Capacitive, and Adhesives), Application ... Banking & Finance), and Geography - Global Trends ... MarketsandMarkets, the global Fingerprint Sensors Market is projected ... a high CAGR of 16.8% from 2014 to ...
(Date:7/29/2014)... 29, 2014 Test instruments after ... and protein soils where it matters most – ... leading manufacturer of premium domestic appliances, introduces ProCare ... instruments are effectively cleaned. The ProCare liquid is ... immediately after processing. After 3 minutes, users visually ...
(Date:7/29/2014)... (CA) method is in principle suitable to find out ... widely use it in health economic evaluations, some (primarily ... the result of a pilot project by the German ... Following the Analytic Hierarchy Process (AHP), CA is the ... experts. , Summarize outcome-specific results to an overall ...
Breaking Medicine News(10 mins):Health News:Leading West Suburban OBGYN Practice, Premier Women’s Health, Joins Allegheny Health Network 2Health News:Leading West Suburban OBGYN Practice, Premier Women’s Health, Joins Allegheny Health Network 3Health News:New IsoComforter Cold Therapy Unit Plus Hip Wrap Gives Post Operative Hip Replacement Patients Faster Recovery Times 2Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 4Health News:ProCare Protein Check Tests Surgical Instruments to Verify Effective Cleaning 2Health News:Determine patient preferences by means of conjoint analysis 2Health News:Determine patient preferences by means of conjoint analysis 3Health News:Determine patient preferences by means of conjoint analysis 4
... Unhappy marriages are harmful to the self-esteem and health of ... to higher levels of psychological distress when compared to those ... as many as 1,150 people in unhappy // marriages ... of sociology, human development and family studies, and demography said ...
... the heart with the progress of age can be postponed by ... which the Journal of the American College of Cardiology has published. ... primary aging can // be delayed by restricting calories in human ... fact has already been proved in the case of small mammals. ...
... regard to the hormone replacement therapy (HRT), another research has put ... to the heart. //The risk of a coronary heart disease is ... the HRT at an younger age, when in comparison to women ... cardiovascular benefits to be seen in the case of women who ...
... Stetson have reported in the Journal Immunity that the host ... infection. // ,Viruses are classified based on their ... found that immune response which acts in recognisation of these ... RNA viruses. ,Immune response against the virus acts ...
... Professor Harvey Lodish and his post-doc Chengcheng Zhang from Whitehead ... of growth factors// which enriches and increases the number of ... into the recipient. ,Stem cell therapy as ... therapy is very high and it requires isolating large number ...
... Neurone Disease (MND), a fatal nerve disease could be improved ... ,Patients suffering from Motor Neurone Disease (MND) could ... works by helping people with MND who suffer from weakness ... reported. ,At present just one drug is licensed ...
Cached Medicine News:
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: